Dr. John Halpern has integrated preliminary comments from the McLean IRB and submitted revised versions of a protocol, informed consent, treatment manual, and the most recent update of the MDMA literature review (January 2003-March 2004) for his MAPS-sponsored proposed study of MDMA-assisted psychotherapy in subjects with anxiety related to advanced-stage cancer.
